|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1814 News |
|
| «12...89101112131415161718...3132» |
- Trial completion, Trial primary completion date: Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine (clinicaltrials.gov) - Dec 13, 2014
P2, N=390, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Active, not recruiting --> Completed | Trial primary completion date: Aug 2013 --> May 2013
- | Trial completion, Trial primary completion date: Quit IT: Development of a Web-based, 3D Coping Skills Game to Increase Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization (clinicaltrials.gov) - Dec 12, 2014
P=N/A, N=20, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed | Trial primary completion date: Aug 2013 --> May 2013 Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Dec 2014
- || Trial primary completion date: Effects of Yoga and Cardiovascular Exercise on Smoking Motivation (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=79, Active, not recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Dec 2014 Trial primary completion date: Feb 2015 --> Jun 2015
- topiramate / Generic mfg.
Trial primary completion date: Topiramate to Aid Smoking Cessation in Alcohol Dependent Men (clinicaltrials.gov) - Dec 10, 2014
P2, N=150, Active, not recruiting, Sponsor: Department of Veterans Affairs
Trial primary completion date: Feb 2015 --> Jun 2015 Trial primary completion date: Jun 2014 --> Nov 2014
- Avastin (bevacizumab) / Roche
Enrollment closed, Trial primary completion date: Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers (clinicaltrials.gov) - Dec 10, 2014
P2, N=40, Active, not recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
Trial primary completion date: Jun 2014 --> Nov 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2014 --> Nov 2015
- Trial primary completion date, HEOR: Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (clinicaltrials.gov) - Dec 9, 2014
P=N/A, N=150, Recruiting, Sponsor: Wayne State University
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2014 --> Nov 2015 Trial primary completion date: Dec 2014 --> Jun 2015
- Trial primary completion date: Hutchinson Study of High School Smoking (clinicaltrials.gov) - Dec 9, 2014
P3, N=2151, Active, not recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Trial primary completion date: Dec 2014 --> Jun 2015 Trial primary completion date: Dec 2014 --> Nov 2015
- Enrollment change, Trial termination: Effects of Message Content on Intention to Quit Smoking (clinicaltrials.gov) - Dec 9, 2014
P=N/A, N=17, Terminated, Sponsor: University of Stirling
Trial primary completion date: Dec 2014 --> Nov 2015 N=140 --> 17 | Not yet recruiting --> Terminated; Student study which ended at the end of their course.
- Trial initiation date: Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients (clinicaltrials.gov) - Dec 9, 2014
P4, N=20, Not yet recruiting, Sponsor: University of Cincinnati
N=140 --> 17 | Not yet recruiting --> Terminated; Student study which ended at the end of their course. Initiation date: Jun 2014 --> Dec 2014
- ||| Chantix (varenicline) / Pfizer
Phase classification, Enrollment change: Varenicline Pregnancy Cohort Study (clinicaltrials.gov) - Dec 9, 2014
P4, N=371, Enrolling by invitation, Sponsor: Pfizer
Initiation date: Jun 2014 --> Dec 2014 Phase classification: P=N/A --> P4 | N=904585 --> 371
- |||| moclobemide / Generic mfg.
Trial completion: RIMA: Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers (clinicaltrials.gov) - Dec 9, 2014
P2, N=76, Completed, Sponsor: Jed E. Rose
Phase classification: P=N/A --> P4 | N=904585 --> 371 Active, not recruiting --> Completed
- Trial primary completion date: Project Quit: Positive vs. Negative Offers of an Online Stop Smoking Program (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=767, Completed, Sponsor: University of Michigan
Active, not recruiting --> Completed Trial primary completion date: Sep 2013 --> Apr 2014
- Trial primary completion date: Effectiveness of Messages to Mobile Phone in Smoke Cessation (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=320, Recruiting, Sponsor: Basque Health Service
Trial primary completion date: Sep 2013 --> Apr 2014 Trial primary completion date: Mar 2014 --> Mar 2015
- || Trial primary completion date: Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=280, Recruiting, Sponsor: University of California, Irvine
Trial primary completion date: Mar 2014 --> Mar 2015 Trial primary completion date: Dec 2013 --> Dec 2017
- Trial primary completion date: Effects of Marijuana Used on Lung Function in Persons With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=300, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Trial primary completion date: Dec 2013 --> Dec 2017 Trial primary completion date: Mar 2014 --> Dec 2015
- Trial primary completion date: Smoking Cessation in Rural Hospitals (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=606, Active, not recruiting, Sponsor: Edward Ellerbeck, MD, MPH
Trial primary completion date: Mar 2014 --> Dec 2015 Trial primary completion date: Oct 2014 --> Feb 2015
- Enrollment closed, Trial primary completion date: RCT-OMSC-PC: Integrating the "Ottawa Model" for Smoking Cessation Into Primary Care Practice (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=20, Active, not recruiting, Sponsor: Ottawa Heart Institute Research Corporation
Trial primary completion date: Oct 2014 --> Feb 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Apr 2015
- | Trial completion, Enrollment change, Trial primary completion date: Communicating Smoking Risks Through Graphic Warning Labels (clinicaltrials.gov) - Dec 6, 2014
P3, N=245, Completed, Sponsor: University of Pennsylvania
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Apr 2015 Recruiting --> Completed | N=320 --> 245 | Trial primary completion date: Jan 2014 --> Apr 2014
- Trial completion: Internet-Based Smoking Cessation for Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=410, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed | N=320 --> 245 | Trial primary completion date: Jan 2014 --> Apr 2014 Active, not recruiting --> Completed
- Trial completion: iQS: A Randomized Trial of Internet Access to Nicotine Patches (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=2485, Completed, Sponsor: University of Michigan
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial termination: ISCWCBTI: Helping Veterans Quit Smoking by Improving Their Sleep (clinicaltrials.gov) - Dec 5, 2014
P2, N=142, Terminated, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed Active, not recruiting --> Terminated; Terminated after two years by CSRD
- | Enbrel (etanercept) / Pfizer, Amgen
Phase classification: Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis (clinicaltrials.gov) - Dec 5, 2014
P4, N=128, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Terminated; Terminated after two years by CSRD Phase classification: P=N/A --> P4
- Enrollment closed: Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=2185, Active, not recruiting, Sponsor: University of Pennsylvania
Phase classification: P=N/A --> P4 Enrolling by invitation --> Active, not recruiting
- Trial completion, Enrollment change: NicEx: The Effect of Exercise on Acute Nicotine Withdrawal (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=88, Completed, Sponsor: University of Pittsburgh
Enrolling by invitation --> Active, not recruiting Recruiting --> Completed | N=150 --> 88
- Trial completion: CAROSS: Carotid Plaque Screening Trial in Smokers (clinicaltrials.gov) - Dec 5, 2014
P4, N=536, Completed, Sponsor: University of Lausanne
Recruiting --> Completed | N=150 --> 88 Active, not recruiting --> Completed
- Trial completion, Enrollment change: Prolonged Smoking Cessation Using Prescription Step Care (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=270, Completed, Sponsor: University of Tennessee
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=400 --> 270
- Trial completion, Enrollment change, Trial primary completion date: Effect of Using a Structured Tobacco Cessation Education Program (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=31, Completed, Sponsor: State University of New York - Upstate Medical University
Active, not recruiting --> Completed | N=400 --> 270 Active, not recruiting --> Completed | N=40 --> 31 | Trial primary completion date: Mar 2009 --> Jun 2009
- Enrollment open, Trial initiation date: An Exercise App to Reduce Young Adults' MJ Use (clinicaltrials.gov) - Nov 28, 2014
P=N/A, N=52, Recruiting, Sponsor: State University of New York at Buffalo
Active, not recruiting --> Completed | N=40 --> 31 | Trial primary completion date: Mar 2009 --> Jun 2009 Not yet recruiting --> Recruiting | Initiation date: May 2013 --> Oct 2014
- Chantix (varenicline) / Pfizer
Trial completion, Trial primary completion date: Smoking Cessation Intervention for Thoracic Patients (clinicaltrials.gov) - Nov 23, 2014
P1/2, N=49, Completed, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting | Initiation date: May 2013 --> Oct 2014 Active, not recruiting --> Completed | Trial primary completion date: Nov 2009 --> Apr 2012
- Enrollment closed: Kids Safe and Smokefree (KiSS) (clinicaltrials.gov) - Nov 20, 2014
P=N/A, N=319, Active, not recruiting, Sponsor: Temple University
Active, not recruiting --> Completed | Trial primary completion date: Nov 2009 --> Apr 2012 Recruiting --> Active, not recruiting
- Trial completion: Cigarette and Gastric Contents (clinicaltrials.gov) - Nov 19, 2014
P=N/A, N=20, Completed, Sponsor: Lionel Bouvet
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Trial completion, Enrollment change: BCBSM-OE: Tobacco Tactics Website for Operating Engineers (clinicaltrials.gov) - Nov 18, 2014
P3, N=232, Completed, Sponsor: University of Michigan
Recruiting --> Completed Active, not recruiting --> Completed | N=100 --> 232
- Enrollment closed: Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation (clinicaltrials.gov) - Nov 11, 2014
P2, N=90, Active, not recruiting, Sponsor: University of Connecticut Health Center
Active, not recruiting --> Completed | N=100 --> 232 Recruiting --> Active, not recruiting
- Trial primary completion date: Contingency Management for Smoking Cessation in the Homeless (clinicaltrials.gov) - Nov 10, 2014
P=N/A, N=70, Recruiting, Sponsor: University of Connecticut Health Center
Recruiting --> Active, not recruiting Trial primary completion date: Oct 2015 --> Oct 2016
- Trial primary completion date: Development of Positive Psychotherapy for Smoking Cessation (clinicaltrials.gov) - Nov 7, 2014
P2, N=80, Active, not recruiting, Sponsor: Brown University
Trial primary completion date: Oct 2015 --> Oct 2016 Trial primary completion date: Dec 2013 --> Jun 2015
- ||| Chantix (varenicline) / Pfizer
Enrollment closed: ConNic5: Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers (clinicaltrials.gov) - Nov 7, 2014
P2, N=280, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Dec 2013 --> Jun 2015 Recruiting --> Active, not recruiting
- Chantix (varenicline) / Pfizer
Trial completion, Enrollment change, Trial primary completion date: ViRT: Varenicline in Drug Treatment (clinicaltrials.gov) - Nov 7, 2014
P4, N=33, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Active, not recruiting Recruiting --> Completed | N=50 --> 33 | Trial primary completion date: Mar 2015 --> Sep 2014
- Trial primary completion date: SSTOP: Smoking Cessation Intervention for Diabetic Patients (clinicaltrials.gov) - Nov 7, 2014
P1/2, N=72, Recruiting, Sponsor: Rhode Island Hospital
Recruiting --> Completed | N=50 --> 33 | Trial primary completion date: Mar 2015 --> Sep 2014 Trial primary completion date: Aug 2013 --> Aug 2015
- Trial completion, Enrollment change: Mobi-Smoke: Mobile Sensing of Smoking Behavior (clinicaltrials.gov) - Nov 5, 2014
P=N/A, N=2, Completed, Sponsor: Duke University
Trial primary completion date: Aug 2013 --> Aug 2015 Recruiting --> Completed | N=30 --> 2
- ||| Chantix (varenicline) / Pfizer
Trial initiation date: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Nov 4, 2014
P4, N=6800, Recruiting, Sponsor: Pfizer
Recruiting --> Completed | N=30 --> 2 Initiation date: Jan 2012 --> May 2012
- | Chantix (varenicline) / Pfizer
Trial completion, Enrollment change: Varenicline In-Patient Study (clinicaltrials.gov) - Nov 4, 2014
P2, N=17, Completed, Sponsor: Stanford University
Initiation date: Jan 2012 --> May 2012 Recruiting --> Completed | N=80 --> 17
- Trial completion, Trial primary completion date: Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge (clinicaltrials.gov) - Nov 4, 2014
P=N/A, N=6, Completed, Sponsor: Pharmaceutical Productions Inc.
Recruiting --> Completed | N=80 --> 17 Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Aug 2014
- Trial completion: Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness (clinicaltrials.gov) - Nov 4, 2014
P1, N=98, Completed, Sponsor: University of Medicine and Dentistry of New Jersey
Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Aug 2014 Active, not recruiting --> Completed
- Trial primary completion date: Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting (clinicaltrials.gov) - Nov 3, 2014
P=N/A, N=88, Active, not recruiting, Sponsor: St. Jude Children's Research Hospital
Active, not recruiting --> Completed Trial primary completion date: Sep 2014 --> Dec 2014
- || Trial primary completion date: Lung Inflammation and Lung Metastases From Breast Cancer (clinicaltrials.gov) - Nov 3, 2014
P=N/A, N=400, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Trial primary completion date: Sep 2014 --> Dec 2014 Trial primary completion date: Aug 2014 --> Aug 2015
- || Enrollment closed: The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease (clinicaltrials.gov) - Nov 3, 2014
P=N/A, N=110, Active, not recruiting, Sponsor: St. Jude Children's Research Hospital
Trial primary completion date: Aug 2014 --> Aug 2015 Recruiting --> Active, not recruiting
- Enrollment closed, Trial primary completion date: Hatha Yoga for Smoking Cessation (clinicaltrials.gov) - Oct 31, 2014
P=N/A, N=120, Active, not recruiting, Sponsor: Creighton University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2014 --> Dec 2014
- Trial primary completion date: Contingency Management for Smoking Cessation in the Homeless (clinicaltrials.gov) - Oct 30, 2014
P=N/A, N=70, Recruiting, Sponsor: University of Connecticut Health Center
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2014 --> Dec 2014 Trial primary completion date: Oct 2014 --> Oct 2015
- Trial primary completion date: Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation (clinicaltrials.gov) - Oct 30, 2014
P2, N=90, Recruiting, Sponsor: University of Connecticut Health Center
Trial primary completion date: Oct 2014 --> Oct 2015 Trial primary completion date: Sep 2014 --> Dec 2014
- | Trial termination: Relapse Prevention Study in Newly Abstinent Smokers (clinicaltrials.gov) - Oct 30, 2014
P2, N=425, Terminated, Sponsor: GlaxoSmithKline
Trial primary completion date: Sep 2014 --> Dec 2014 Withdrawn --> Terminated; Study halted prior to enrollment of patients